Status:
COMPLETED
An Evaluation of a Antimicrobial Stewardship Recommendation Bundle for Staphylococcus Aureus Bloodstream Infections
Lead Sponsor:
Methodist Health System
Conditions:
Bacterial Infections
Eligibility:
All Genders
18-85 years
Brief Summary
In July 2020, a bundle (Appendix C) was implemented at Methodist Dallas Medical Center where all patients with SAB were reviewed by the antimicrobial stewardship pharmacist (Monday - Friday from 0700 ...
Detailed Description
Evaluation of the Staphylococcus aureus bloodstream infection(SAB)bundle recommendations will allow for determination of whether this intervention is impactful and warrants the resources currently dev...
Eligibility Criteria
Inclusion
- 18 years of age SAB during hospital admission
Exclusion
- Patients with a history of a prior SAB during the study period (only first occurrence included)
- Blood culture collected within 48hours of patient expiring or transitioning to hospice
- Patients discharged or left before culture results were available
- Patients transferred from an outside hospital
Key Trial Info
Start Date :
May 18 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 14 2025
Estimated Enrollment :
77 Patients enrolled
Trial Details
Trial ID
NCT06211829
Start Date
May 18 2022
End Date
July 14 2025
Last Update
August 6 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Methodist Dallas Medical Center
Dallas, Texas, United States, 75203